Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
2.490
+0.090 (3.75%)
Oct 24, 2025, 1:55 PM EDT
Nuo Therapeutics Market Cap
Nuo Therapeutics has a market cap or net worth of $119.23 million as of October 24, 2025. Its market cap has increased by 254.36% in one year.
Market Cap
119.23M
Enterprise Value
119.05M
Revenue
1.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.49
Market Cap Chart
Since February 14, 2017, Nuo Therapeutics's market cap has increased from 19.85M to 119.23M, an increase of 500.54%. That is a compound annual growth rate of 22.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 119.23M | 81.92% |
| Dec 31, 2024 | 65.54M | 169.36% |
| Dec 29, 2023 | 24.33M | -61.19% |
| Dec 23, 2022 | 62.70M | 360.46% |
| Dec 31, 2020 | 13.62M | 378.33% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 649.45M |
| Glass House Brands | 618.32M |
| Silence Therapeutics | 342.45M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 319.35M |
| Northwest Biotherapeutics | 305.00M |
| American Oncology Network | 297.14M |